APP and Alzheimer disease: Although the APP mutations in Group 2 can cause decreases in Aβ production in cellular models compared to WT APP, patients with E693G, E693K, and E693Q mutations still showed extracellular amyloid deposition, CAA and typical clinical features of AD.